Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma HRP2 Measurement

English version České info

Background:
In African children, distinguishing severe falciparum malaria from other severe febrile illnesses with coincidental Plasmodium falciparum parasitaemia is a major challenge. P. falciparum histidine-rich protein 2 (PfHRP2) is released by mature sequestered parasites and can be used to estimate the total parasite burden. We investigated the prognostic significance of plasma PfHRP2 and used it to estimate the malaria-attributable fraction in African children diagnosed with severe malaria.

Methods and Findings:
Admission plasma PfHRP2 was measured prospectively in African children (from Mozambique, The Gambia, Kenya, Tanzania, Uganda, Rwanda, and the Democratic Republic of the Congo) aged 1 month to 15 years with severe febrile illness and a positive P. falciparum lactate dehydrogenase (pLDH)-based rapid test in a clinical trial comparing parenteral artesunate versus quinine (the AQUAMAT trial, ISRCTN 50258054). In 3,826 severely ill children, Plasmadium falciparum PfHRP2 was higher in patients with coma (p = 0.0209), acidosis (p<0.0001), and severe anaemia (p<0.0001). Admission geometric mean (95%CI) plasma PfHRP2 was 1,611 (1,350–1,922) ng/mL in fatal cases (n = 381) versus 1,046 (991–1,104) ng/mL in survivors (n = 3,445, p<0.0001), without differences in parasitaemia as assessed by microscopy. There was a U-shaped association between log₁₀ plasma PfHRP2 and risk of death. Mortality increased 20% per log₁₀ increase in PfHRP2 above 174 ng/mL (adjusted odds ratio [AOR] 1.21, 95%CI 1.05–1.39, p = 0.009). A mechanistic model assuming a PfHRP2-independent risk of death in non-malaria illness closely fitted the observed data and showed malaria-attributable mortality less than 50% with plasma PfHRP2≤174 ng/mL. The odds ratio (OR) for death in artesunate versus quinine-treated patients was 0.61 (95%CI 0.44–0.83, p = 0.0018) in the highest PfHRP2 tertile, whereas there was no difference in the lowest tertile (OR 1.05; 95%CI 0.69–1.61; p = 0.82). A limitation of the study is that some conclusions are drawn from a mechanistic model, which is inherently dependent on certain assumptions. However, a sensitivity analysis of the model indicated that the results were robust to a plausible range of parameter estimates. Further studies are needed to validate our findings.

Conclusions:
Plasma PfHRP2 has prognostic significance in African children with severe falciparum malaria and provides a tool to stratify the risk of “true” severe malaria-attributable disease as opposed to other severe illnesses in parasitaemic African children.

Please see later in the article for the Editors' Summary.

Vyšlo v časopise: Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma HRP2 Measurement. PLoS Med 9(8): e32767. doi:10.1371/journal.pmed.1001297
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001297

Souhrn

Zdroje

1. EnglishM, PuntJ, MwangiI, McHughK, MarshK (1996) Clinical overlap between malaria and severe pneumonia in Africa children in hospital. Trans R Soc Trop Med Hyg 90: 658–662.

2. BerkleyJ, MwarumbaS, BramhamK, LoweB, MarshK (1999) Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med 93: 283–286.

3. EvansJA, AduseiA, TimmannC, MayJ, MackD, et al. (2004) High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM 97: 591–597.

4. TaylorTE, FuWJ, CarrRA, WhittenRO, MuellerJS, et al. (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10: 143–145.

5. BerkleyJA, LoweBS, MwangiI, WilliamsT, BauniE, et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39–47.

6. ReyburnH, MbatiaR, DrakeleyC, CarneiroI, MwakasungulaE, et al. (2004) Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 329: 1212.

7. DondorpAM, PongponratnE, WhiteNJ (2004) Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop 89: 309–317.

8. MarshK, ForsterD, WaruiruC, MwangiI, WinstanleyM, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399–1404.

9. JaffarS, Van HensbroekMB, PalmerA, SchneiderG, GreenwoodB (1997) Predictors of a fatal outcome following childhood cerebral malaria. Am J Trop Med Hyg 57: 20–24.

10. SilamutK, WhiteNJ (1993) Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg 87: 436–443.

11. NguyenPH, DayN, PramTD, FergusonDJ, WhiteNJ (1995) Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 89: 200–204.

12. HowardRJ, UniS, AikawaM, AleySB, LeechJH, et al. (1986) Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol 103: 1269–1277.

13. KifudeCM, RajasekariahHG, SullivanDJJr, StewartVA, AngovE, et al. (2008) Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum. Clin Vaccine Immunol 15: 1012–1018.

14. DesakornV, DondorpAM, SilamutK, PongtavornpinyoW, SahassanandaD, et al. (2005) Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg 99: 517–524.

15. DondorpAM, DesakornV, PongtavornpinyoW, SahassanandaD, SilamutK, et al. (2005) Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2: e204 doi:10.1371/journal.pmed.0020204.

16. YeoTW, LampahDA, GitawatiR, TjitraE, KenangalemE, et al. (2008) Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA 105: 17097–17102.

17. DondorpAM, FanelloCI, HendriksenIC, GomesE, SeniA, et al. (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 1647–1657.

18. GreenwoodBM, ArmstrongJR (1991) Comparison of two simple methods for determining malaria parasite density. Trans R Soc Trop Med Hyg 85: 186–188.

19. PlancheT, KrishnaS, KombilaM, EngelK, FaucherJF, et al. (2001) Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 65: 599–602.

20. BakerJ, GattonML, PetersJ, HoMF, McCarthyJS, et al. (2011) Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One 6: e22593 doi:10.1371/journal.pone.0022593.

21. DeansAM, LykeKE, TheraMA, PloweCV, KoneA, et al. (2006) Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am J Trop Med Hyg 74: 554–563.

22. Le ScanfC, Vigan-WomasI, ContaminH, GuillotteM, BischoffE, et al. (2008) Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey. Microbes Infect 10: 447–451.

23. ChotivanichK, UdomsangpetchR, SimpsonJA, NewtonP, PukrittayakameeS, et al. (2000) Parasite multiplication potential and the severity of Falciparum malaria. J Infect Dis 181: 1206–1209.

24. SimpsonJA, AaronsL, CollinsWE, JefferyGM, WhiteNJ (2002) Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124: 247–263.

25. SilamutK, PhuNH, WhittyC, TurnerGD, LouwrierK, et al. (1999) A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol 155: 395–410.

26. StataCorp (2007) Stata 10 Base Reference Manual (L): College Station, TX: Stata Press.

27. BerkleyJA, BejonP, MwangiT, GwerS, MaitlandK, et al. (2009) HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 49: 336–343.

28. DondorpAM, InceC, CharunwatthanaP, HansonJ, van KuijenA, et al. (2008) Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis 197: 79–84.

29. WhiteVA, LewallenS, BeareNA, MolyneuxME, TaylorTE (2009) Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One 4: e4317 doi:10.1371/journal.pone.0004317.

30. BeareNA, HardingSP, TaylorTE, LewallenS, MolyneuxME (2009) Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis 199: 263–271.

31. MacPhersonGG, WarrellMJ, WhiteNJ, LooareesuwanS, WarrellDA (1985) Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 119: 385–401.

32. DondorpA, NostenF, StepniewskaK, DayN, WhiteN (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366: 717–725.

33. BejonP, BerkleyJA, MwangiT, OgadaE, MwangiI, et al. (2007) Defining childhood severe falciparum malaria for intervention studies. PLoS Med 4: e251 doi: 10.1371/journal.pmed.0040251.

34. BurtonM, Nyong'oO, BurtonK, JohnW, InkoomE, et al. (2004) Retinopathy in Gambian children admitted to hospital with malaria. Trop Doct 34: 214–218.

35. BeareNA, TaylorTE, HardingSP, LewallenS, MolyneuxME (2006) Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 75: 790–797.

36. EssumanVA, Ntim-AmponsahCT, AstrupBS, AdjeiGO, KurtzhalsJA, et al. (2010) Retinopathy in severe malaria in Ghanaian children–overlap between fundus changes in cerebral and non-cerebral malaria. Malar J 9: 232.

37. BeareNA, SouthernC, ChaliraC, TaylorTE, MolyneuxME, et al. (2004) Prognostic significance and course of retinopathy in children with severe malaria. Arch Ophthalmol 122: 1141–1147.

38. BiswasS, TomarD, RaoDN (2005) Investigation of the kinetics of histidine-rich protein 2 and of the antibody responses to this antigen, in a group of malaria patients from India. Ann Trop Med Parasitol 99: 553–562.

39. AbekuTA, KristanM, JonesC, BeardJ, MuellerDH, et al. (2008) Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J 7: 202.

40. ManningL, LamanM, StanisicD, Rosanas-UrgellA, BonaC, et al. (2011) Plasma Plasmodium falciparum histidine-rich protein-2 concentrations do not reflect severity of malaria in Papua new guinean children. Clin Infect Dis 52: 440–446.

41. BakerJ, McCarthyJ, GattonM, KyleDE, BelizarioV, et al. (2005) Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis 192: 870–877.

42. MartinSK, RajasekariahGH, AwindaG, WaitumbiJ, KifudeC (2009) Unified parasite lactate dehydrogenase and histidine-rich protein ELISA for quantification of Plasmodium falciparum. Am J Trop Med Hyg 80: 516–522.

43. BakerJ, HoMF, PelecanosA, GattonM, ChenN, et al. (2010) Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J 9: 129.

44. HouzeS, HubertV, Le PessecG, Le BrasJ, ClainJ (2011) Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic test. J Clin Microbiol 49: 2694–2696.

45. KoitaOA, DoumboOK, OuattaraA, TallLK, KonareA, et al. (2012) False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg 86: 194–198.

46. WellemsTE, WallikerD, SmithCL, do RosarioVE, MaloyWL, et al. (1987) A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell 49: 633–642.

47. Walker-JonahA, DolanSA, GwadzRW, PantonLJ, WellemsTE (1992) An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. Mol Biochem Parasitol 51: 313–320.